All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
ASMB / Assembly Biosciences, Inc.
|
|
|
|
|
|
|
|
US62857M1053 / MyoKardia, Inc.
|
|
|
|
|
|
|
|
YMTX / Yumanity Therapeutics Inc
|
|
|
|
|
|
|
|
CHAC.WS / Chardan Healthcare Acquisition Corp.
|
|
|
|
|
|
|
|
FLDM / Standard BioTools Inc
|
|
|
|
|
|
|
|
OPTN / OptiNose, Inc.
|
|
|
|
|
|
|
|
QGEN / Qiagen N.V.
|
|
|
|
|
|
|
|
KIDS / OrthoPediatrics Corp.
|
|
|
|
|
|
|
|
CNCE / Concert Pharmaceuticals Inc
|
|
|
|
|
|
|
|
STIM / Neuronetics, Inc.
|
|
|
|
|
|
|
|
ECOR / electroCore, Inc.
|
|
|
|
|
|
|
|
PACB / Pacific Biosciences of California, Inc.
|
|
|
|
|
|
|
|
928551AB6 / Vivus Inc Bond
|
|
|
|
|
|
|
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
928551AA8 / VIVUS, Inc. Bond
|
|
|
|
|
|
|
|
SIBN / SI-BONE, Inc.
|
|
|
|
|
|
|
|
NVTR / Nuvectra Corporation
|
|
|
|
|
|
|
|
CDNA / CareDx, Inc
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
CORI / Corium International, Inc.
|
|
|
|
|
|
|
|
MRKR / Marker Therapeutics, Inc.
|
|
|
|
|
|
|
|
ODT / Odonate Therapeutics Inc
|
|
|
|
|
|
|
|
US74257L1089 / Principia Biopharma Inc.
|
|
|
|
|
|
|
|
RMD / ResMed Inc.
|
|
|
|
|
|
|
|
LIVN / LivaNova PLC Put
|
|
|
|
|
|
|
|
LIVN / LivaNova PLC
|
|
|
|
|
|
|
|
PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
QURE / uniQure N.V.
|
|
|
|
|
|
|
|
RMED / Catheter Precision Inc.
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
MASI / Masimo Corporation
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
MOTS / Motus GI Holdings, Inc.
|
|
|
|
|
|
|
|
ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
VIVE / Viveve Medical, Inc.
|
|
|
|
|
|
|
|
AXNX / Axonics, Inc.
|
|
|
|
|
|
|
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
FIXX / Homology Medicines, Inc.
|
|
|
|
|
|
|
|
SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
SLDB / Solid Biosciences Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VRAY / ViewRay Inc.
|
|
|
|
|
|
|
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
VCEL / Vericel Corporation
|
|
|
|
|
|
|
|
VKTX / Viking Therapeutics, Inc.
|
|
|
|
|
|
|
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ESTA / Establishment Labs Holdings Inc.
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|